145 related articles for article (PubMed ID: 26454569)
1. Lower Total Knee Arthroplasty Revision Risk Associated With Bisphosphonate Use, Even in Patients With Normal Bone Density.
Namba RS; Inacio MC; Cheetham TC; Dell RM; Paxton EW; Khatod MX
J Arthroplasty; 2016 Feb; 31(2):537-41. PubMed ID: 26454569
[TBL] [Abstract][Full Text] [Related]
2. Association of Bisphosphonate Use and Risk of Revision After THA: Outcomes From a US Total Joint Replacement Registry.
Khatod M; Inacio MC; Dell RM; Bini SA; Paxton EW; Namba RS
Clin Orthop Relat Res; 2015 Nov; 473(11):3412-20. PubMed ID: 25896134
[TBL] [Abstract][Full Text] [Related]
3. Postoperative Bisphosphonates Use is Associated with Reduced Adverse Outcomes After Primary Total Joint Arthroplasty of Hip and Knee: A Nationwide Population-Based Cohort Study.
Shih JT; Tan TL; Shen PH; Yeh TT; Wu CC; Pan RY; Chien WC; Chung CH; Wang SH
Calcif Tissue Int; 2024 May; 114(5):451-460. PubMed ID: 38492035
[TBL] [Abstract][Full Text] [Related]
4. Atypical periprosthetic femoral fracture: a case report.
Woo SB; Choi ST; Chan WL
J Orthop Surg (Hong Kong); 2016 Aug; 24(2):269-72. PubMed ID: 27574277
[TBL] [Abstract][Full Text] [Related]
5. The use of bisphosphonates after joint arthroplasty is associated with lower implant revision rate.
Ro DH; Jin H; Park JY; Lee MC; Won S; Han HS
Knee Surg Sports Traumatol Arthrosc; 2019 Jul; 27(7):2082-2089. PubMed ID: 30547306
[TBL] [Abstract][Full Text] [Related]
6. Bisphosphonate Use and the Risk of Undergoing Total Knee Arthroplasty in Osteoporotic Patients with Osteoarthritis: A Nationwide Cohort Study in Taiwan.
Fu SH; Wang CY; Yang RS; Wu FL; Hsiao FY
J Bone Joint Surg Am; 2017 Jun; 99(11):938-946. PubMed ID: 28590379
[TBL] [Abstract][Full Text] [Related]
7. Effect of bisphosphonates on periprosthetic bone loss after total knee arthroplasty: a meta-analysis of randomized controlled trials.
Shi M; Chen L; Wu H; Wang Y; Wang W; Zhang Y; Yan S
BMC Musculoskelet Disord; 2018 May; 19(1):177. PubMed ID: 29848366
[TBL] [Abstract][Full Text] [Related]
8. Bisphosphonate Use and Risk of Implant Revision after Total Hip/Knee Arthroplasty: A Meta-Analysis of Observational Studies.
Teng S; Yi C; Krettek C; Jagodzinski M
PLoS One; 2015; 10(10):e0139927. PubMed ID: 26444555
[TBL] [Abstract][Full Text] [Related]
9. Initiation of Bisphosphonates Prior to Total Joint Arthroplasty Does Not Lower Periprosthetic Fracture Risk.
Lee A; Durst CR; Rajaee SS
J Arthroplasty; 2024 Jun; 39(6):1459-1462. PubMed ID: 38070715
[TBL] [Abstract][Full Text] [Related]
10. Rare non-traumatic periprosthetic femoral fracture with features of an atypical femoral fracture: a case report.
Niikura T; Lee SY; Sakai Y; Kuroda R; Kurosaka M
J Med Case Rep; 2015 May; 9():103. PubMed ID: 25943378
[TBL] [Abstract][Full Text] [Related]
11. Bisphosphonate-associated peri-implant fractures: a new clinical entity? A series of 10 patients with 11 fractures.
Lee JY; Soh T; Howe TS; Koh JS; Kwek EB; Chua DT
Acta Orthop; 2015; 86(5):622-6. PubMed ID: 25817305
[TBL] [Abstract][Full Text] [Related]
12. Denosumab prevents periprosthetic bone mineral density loss in the tibial metaphysis in total knee arthroplasty.
Murahashi Y; Teramoto A; Jimbo S; Okada Y; Kamiya T; Imamura R; Takashima H; Watanabe K; Nagoya S; Yamashita T
Knee; 2020 Mar; 27(2):580-586. PubMed ID: 31928902
[TBL] [Abstract][Full Text] [Related]
13. Younger age is associated with a higher risk of early periprosthetic joint infection and aseptic mechanical failure after total knee arthroplasty.
Meehan JP; Danielsen B; Kim SH; Jamali AA; White RH
J Bone Joint Surg Am; 2014 Apr; 96(7):529-35. PubMed ID: 24695918
[TBL] [Abstract][Full Text] [Related]
14. Distal femoral replacement in periprosthetic fracture around total knee arthroplasty.
Jassim SS; McNamara I; Hopgood P
Injury; 2014 Mar; 45(3):550-3. PubMed ID: 24268192
[TBL] [Abstract][Full Text] [Related]
15. Oral bisphosphonate use and total knee/hip implant survival: validation of results in an external population-based cohort.
Prieto-Alhambra D; Lalmohamed A; Abrahamsen B; Arden NK; de Boer A; Vestergaard P; de Vries F
Arthritis Rheumatol; 2014 Nov; 66(11):3233-40. PubMed ID: 25047677
[TBL] [Abstract][Full Text] [Related]
16. Bisphosphonates for the preservation of periprosthetic bone mineral density after total joint arthroplasty: a meta-analysis of 25 randomized controlled trials.
Shi M; Chen L; Xin Z; Wang Y; Wang W; Yan S
Osteoporos Int; 2018 Jul; 29(7):1525-1537. PubMed ID: 29654342
[TBL] [Abstract][Full Text] [Related]
17. [Distal femoral periprosthetic fractures: classification and therapy].
Tomás T; Nachtnebl L; Otiepka P
Acta Chir Orthop Traumatol Cech; 2010 Jun; 77(3):194-202. PubMed ID: 20619110
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous acetabular periprosthetic fracture in a patient continuously having zoledronic acid.
Tantavisut S; Tanavalee A; Thanakit V; Ngarmukos S; Wilairatana V; Wangroongsub Y
Clin Orthop Surg; 2014 Sep; 6(3):358-60. PubMed ID: 25177464
[TBL] [Abstract][Full Text] [Related]
19. [Periprosthetic Femoral Fractures after Total Hip Replacement: Our Results and Treatment Complications].
Pavelka T; Salášek M; Weisová D
Acta Chir Orthop Traumatol Cech; 2017; 84(1):52-58. PubMed ID: 28253947
[TBL] [Abstract][Full Text] [Related]
20. The Fate of Revision Total Knee Arthroplasty With Preoperative Abnormalities in Either Sedimentation Rate or C-Reactive Protein.
Hardcastle JM; So DH; Lee GC
J Arthroplasty; 2016 Dec; 31(12):2831-2834. PubMed ID: 27498389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
